HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Loco-regional intra-arterial chemotherapy combined with radiotherapy in cervical carcinoma].

Abstract
Fifteen patients with squamous cell carcinoma of the uterine cervix--7 in stage II, 6 in stage III and 2 in stage IV--were considered not to respond at the end of radiotherapy. Therefore, the whole patient population underwent bilateral intraarterial chemotherapy with Mitomycin-C (3 cycles, 3-4 weeks' intervals). Patients' responses were evaluated with clinical and CT examinations following irradiation and after completing chemotherapy. Pelvic irradiation was administered by external beams (6 Mv), for a 50-Gy dosage (200 cGy/day for 5 weeks); in 4 cases treatment was completed by means of brachytherapy (192 Ir), with 20-25 Gy dosage. Intraarterial infusion was carried out after positioning the catheters in both uterine arteries; in 5 cases, the internal iliac artery alone was cannulated. At the end of the combined treatment, 2 patients (13%) responded completely, 9 (60%) partially and 4 (27%) not at all. Mean survival was 24 months. No hematologic complication was so severe that treatment had to be discontinued. In 4 patients chemotherapy caused a partially ulcerated skin erythema in the buttocks, which was completely cured in all cases.
AuthorsM Trinci, N Raffetto, F Salvatori, C Trinci
JournalLa Radiologia medica (Radiol Med) Vol. 85 Issue 3 Pg. 262-5 (Mar 1993) ISSN: 0033-8362 [Print] Italy
Vernacular TitleLa chemioterapia intra-arteriosa loco-regionale associata alla radioterapia nel cervicocarcinoma.
PMID8493375 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Mitomycin
Topics
  • Carcinoma, Squamous Cell (drug therapy, radiotherapy, therapy)
  • Combined Modality Therapy
  • Female
  • Humans
  • Infusions, Intra-Arterial
  • Mitomycin (administration & dosage, therapeutic use)
  • Uterine Cervical Neoplasms (drug therapy, radiotherapy, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: